Hydrocortisone Sodium Succinate Injection — FDA Drug Shortage

No longer listed by FDA — Cipla Limited

The FDA lists a drug shortage record for Hydrocortisone Sodium Succinate Injection (injection) from Cipla Limited with status No longer listed by FDA. The shortage was first posted on Mar 24, 2023.

Shortage details

Status
No longer listed by FDA
Company
Cipla Limited
Package NDC
69097-004-67
Dosage Form
Injection
Presentation
Hydrocortisone Sodium Succinate, Injection, 100 mg/ Vial (NDC 69097-004-67)
Initial Posting
Mar 24, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.